Robert Bain Thomas, Director at REVA Medical, Inc. (RVA.AX), bought 5,000 shares at $1.74 ($9K) on 2018-06-14, disclosed to the SEC on 2018-06-15.
Open-market purchase of $9k RVA.AX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.86 | 2,500 | $5K | 51.7% |
| 2 | $1.74 | 2,500 | $4K | 48.3% |
| Total | $1.80 avg | 5,000 | $9K | 100% |
| Filing → |
| RVA.AX | BUY | 2018-03-30 | $15K | — | Filing → |
| RVA.AX | BUY | 2018-03-28 | $15K | — | Filing → |
| RVA | BUY | 2016-07-19 | $224K | — | Filing → |